Cure Vac N.V. Appoints Thaminda Ramanayake As Chief Business Officer
04/29/24, 3:18 AM
Location
tübingenIndustry
biotechnology
health care
Position
chief business officer
CureVac N.V., a global biopharmaceutical company, has announced the appointment of Thaminda Ramanayake to the role of Chief Business Officer, effective June 1, 2024. Mr. Ramanayake brings over fifteen years of experience in biopharma company development and deal-making, with a strong track record of successful clinical collaborations, M&A, asset in-licensing, and strategic financing initiatives across multiple therapeutic areas.
Company Info
Location
tübingen, baden-württemberg, germany
Additional Info
CureVac N.V. is a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA). CureVac has more than 20 years of expertise in developing, optimizing, and manufacturing mRNA for medical purposes. The company focuses on using optimized mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.